Clinical features and therapeutic schedule of 7 patients with idiopathic retroperitoneal fibrosis

Chenni GAO,Pingyan SHEN,Zhaocheng PAN,Wen ZHANG,Xiaonong CHEN

2017-01-01

Abstract:Objective To explore the clinical features,treatment and prognosis of idiopathic retroperitoneal fibrosis (RPF).Methods The clinical data including clinical manifestations,laboratory and imaging results,therapeutic schedule and prognosis of 7 RPF patients diagnosed between 2011 and 2016 in our hospital were retrospectively analyzed.Results There were 6 males and 1 female with an average age of 55 years.The initial symptoms were polydipsia and polyuria in 1 patient,abdominal and lumbar pain in 2 patients.Physical examination was abnormal in 4 patients.Six patients had renal function impairment with elevated C-reactionprotein and all of them had elevated erythrocyte sedimentation rate.All patients underwent urological CT scan or MRI,showing parenchyma wrapping around the abdominal aorta,iliac artery,ureter,even renal vessels or other retroperitoneal organs,which accorded with the diagnosis of RPF.Biopsy was performed in 4 patients,and the results showed fibrous tissue hyperplasia with lymphocyte and plasmocyte infiltration.Double J catheter was implanted in 3 patients.One patient underwent pyelostemy to relieve obstructive symptoms.Hemodialysis was performed to deal with elevated serum creatinine in 4 patients.One patient was treated by glucocorticoid,and other 6 by glucocorticoid and immunosuppressive agents (1 patient was eventually treated with rituximab after glucocorticoid combined with multiple immunosuppressive agents such as mycophenolate mofetil,cyclophosphamide and pavlin due to cortico-dependency and recurrence,and other five were treated with glucocorticoid combined with cyclophosphamide).The mean follow-up time was 23.0 months (range,3-56 months).One died of infection caused by myelosuppresion after cyclophosphamide therapy.Nobody manifested obstructive symptoms again or developed to end-stage renal disease.The cortico-dependent patient with multiple relapses was finally treated with rituximab.Oral prednisolone was gradually dropped off during the follow-up,the renal function remained stable,and no complications just like allergy or infection occurred.Conclusion No typical clinical manifestations is found in RPF patients.Imaginary examination plays an important role in the diagnosis.The combination of surgical and medical interventions (glucocorticoid with immunosuppressive agents) is the common therapeutic schedule.For the cortico-dependent patient with multiple relapses,rituximab may be another option,but its efficacy and safety need further proof.